Markerless Image Guidance Using Intrafraction Kilovoltage X-ray Imaging
This trial will investigate the feasibility of the Markerless Tumour Tracking technology.
Trial Details
- NCT ID
- NCT04086082
- Phase
- NA
- Sponsor
- University of Sydney
- Status
- RECRUITING
- Cancer Type
- Lung Cancer
- Interventions
- Markerless Image Guidance
- Locations (sample)
- Melbourne, Victoria, Australia|-37.814,144.96332
Key Eligibility Criteria
- Is willing to comply with all trial procedures and intends to provide written Informed Consent for participation in this trial.
- Patients undergoing external beam radiotherapy.
- Histologically proven Stage I NSCLC or oligometastatic lung metastases (3 or less).
- MRI/4D-CT prior to insertion of fiducial markers.
For full eligibility, visit ClinicalTrials.gov.
Check If You May Be Eligible
Trialify translates complex eligibility criteria into plain yes-or-no questions to help you understand if this trial might be right for you.
Find Lung Cancer Trials on Trialify →